scispace - formally typeset
M

Mary Kaileh

Researcher at National Institutes of Health

Publications -  21
Citations -  992

Mary Kaileh is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Biology & Medicine. The author has an hindex of 7, co-authored 9 publications receiving 869 citations. Previous affiliations of Mary Kaileh include Ghent University.

Papers
More filters
Journal ArticleDOI

Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity.

TL;DR: The results indicate that pure WA or WA-enriched WS extracts can be considered as a novel class of NFκB inhibitors, which hold promise as novel anti-inflammatory agents for treatment of various inflammatory disorders and/or cancer.
Journal ArticleDOI

Tonic B cell antigen receptor signals supply an NF-κB substrate for prosurvival BLyS signaling

TL;DR: This work shows that BCR signaling induced production of the nonclassical transcription factor NF-κB pathway substrate p100, which is required for transmission of BR3 signals and thus B cell survival, and identifies a molecular mechanism for the reliance of primary B cells on continuous BR3 and B CR signaling.
Journal ArticleDOI

Screening of indigenous Palestinian medicinal plants for potential anti-inflammatory and cytotoxic activity.

TL;DR: Whereas Withania somnifera extract demonstrated the strongest NFkappaB-inhibitory activity, other extracts derived from Laurus nobilis, Psidium guajava and Foeniculum vulgare M. (Umbiliferrae) also revealed immunomodulatory NFKappaB activities, and are good candidates for further activity-monitored fractionation to identify active constituents.
Journal ArticleDOI

Molecular insight in the multifunctional activities of Withaferin A

TL;DR: This review provides a decisive insight on the molecular basis of the health-promoting potential of Withaferin A.
Journal Article

Xanthohumol Activates the Proapoptotic Arm of the Unfolded Protein Response in Chronic Lymphocytic Leukemia

TL;DR: X stimulates the proapoptotic arm of the UPR in ex vivo CLL cells, suggesting that ER stress may play an important role during X-induced apoptosis.